Literature DB >> 28279258

Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice.

Mark Schiffman1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28279258      PMCID: PMC5347462          DOI: 10.1016/j.ypmed.2016.12.028

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


× No keyword cloud information.
  9 in total

1.  A review of human carcinogens--Part B: biological agents.

Authors:  Véronique Bouvard; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

2.  Considerations for HPV primary screening in lower-middle income countries.

Authors:  Mauricio Maza; Julia C Gage
Journal:  Prev Med       Date:  2017-02-06       Impact factor: 4.018

3.  Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.

Authors:  Joseph E Tota; James Bentley; Jennifer Blake; François Coutlée; Máire A Duggan; Alex Ferenczy; Eduardo L Franco; Michael Fung-Kee-Fung; Walter Gotlieb; Marie-Hélène Mayrand; Meg McLachlin; Joan Murphy; Gina Ogilvie; Sam Ratnam
Journal:  Prev Med       Date:  2017-02-06       Impact factor: 4.018

4.  Cervical cancer prevention in upper middle-income countries.

Authors:  Ana Cecilia Rodríguez; Jorge Salmerón
Journal:  Prev Med       Date:  2017-02-06       Impact factor: 4.018

5.  Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference.

Authors:  Paolo Giorgi Rossi; Francesca Carozzi; Antonio Federici; Guglielmo Ronco; Marco Zappa; Silvia Franceschi
Journal:  Prev Med       Date:  2016-11-25       Impact factor: 4.018

6.  HPV-based cervical cancer screening- facts, fiction, and misperceptions.

Authors:  Nicolas Wentzensen; Marc Arbyn
Journal:  Prev Med       Date:  2017-02-06       Impact factor: 4.018

7.  Protection against cervical cancer versus decreasing harms from screening - What would U.S. patients and clinicians prefer, and do their preferences matter?

Authors:  Walter K Kinney; Warner K Huh
Journal:  Prev Med       Date:  2017-02-06       Impact factor: 4.018

8.  The time is now to implement HPV testing for primary screening in low resource settings.

Authors:  Louise Kuhn; Lynette Denny
Journal:  Prev Med       Date:  2017-02-06       Impact factor: 4.018

9.  Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.

Authors:  Joseph E Tota; James Bentley; Jennifer Blake; François Coutlée; Máire A Duggan; Alex Ferenczy; Eduardo L Franco; Michael Fung-Kee-Fung; Walter Gotlieb; Marie-Hélène Mayrand; Meg McLachlin; Joan Murphy; Gina Ogilvie; Sam Ratnam
Journal:  Prev Med       Date:  2017-02-06       Impact factor: 4.018

  9 in total
  11 in total

1.  Voltammetric determination of human papillomavirus 16 DNA by using interdigitated electrodes modified with titanium dioxide nanoparticles.

Authors:  Nor A Parmin; Uda Hashim; Subash C B Gopinath; Sharipah Nadzirah; Zulida Rejali; Amilia Afzan; M N A Uda; V C Hong; R D A A Rajapaksha
Journal:  Mikrochim Acta       Date:  2019-05-08       Impact factor: 5.833

2.  Connaissances, utilisation et obstacles liés au dépistage du cancer du col utérin dans des hôpitaux de district de Kigali, au Rwanda.

Authors:  Gaudence Niyonsenga; Darius Gishoma; Ruth Sego; Marie Goretti Uwayezu; Bellancille Nikuze; Margaret Fitch; Pierre Céléstin Igiraneza
Journal:  Can Oncol Nurs J       Date:  2021-07-01

3.  Knowledge, utilization and barriers of cervical cancer screening among women attending selected district hospitals in Kigali - Rwanda.

Authors:  Gaudence Niyonsenga; Darius Gishoma; Ruth Sego; Marie Goretti Uwayezu; Bellancille Nikuze; Margaret Fitch; Pierre Céléstin Igiraneza
Journal:  Can Oncol Nurs J       Date:  2021-07-01

4.  Long non-coding RNA HOTAIR regulates proliferation, migration and invasion of human cervical cancer cells by modulating expression of MAPK1.

Authors:  Haiying Liu; Jing Liu; Guangzhang Zhao
Journal:  Arch Med Sci       Date:  2019-03-11       Impact factor: 3.318

Review 5.  Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.

Authors:  Sarah Gupta; Christina Palmer; Elisabeth M Bik; Juan P Cardenas; Harold Nuñez; Laurens Kraal; Sara W Bird; Jennie Bowers; Alison Smith; Nathaniel A Walton; Audrey D Goddard; Daniel E Almonacid; Susan Zneimer; Jessica Richman; Zachary S Apte
Journal:  Front Public Health       Date:  2018-04-09

6.  circ-MYBL2 Serves As A Sponge For miR-361-3p Promoting Cervical Cancer Cells Proliferation And Invasion.

Authors:  Jinrong Wang; Hui Li; Zhen Liang
Journal:  Onco Targets Ther       Date:  2019-11-20       Impact factor: 4.147

7.  TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.

Authors:  Liuyan Chen; Jilin Qing; Yangyang Xiao; Xiaomei Huang; Yanlin Chi; Zhizhong Chen
Journal:  BMC Cancer       Date:  2022-04-07       Impact factor: 4.430

8.  KIF14 affects cell cycle arrest and cell viability in cervical cancer by regulating the p27Kip1 pathway.

Authors:  Jie Zhang; Gulimire Buranjiang; Zuohelaguli Mutalifu; Hua Jin; Liyan Yao
Journal:  World J Surg Oncol       Date:  2022-04-19       Impact factor: 3.253

9.  MIR210HG promotes cell proliferation and invasion by regulating miR-503-5p/TRAF4 axis in cervical cancer.

Authors:  Ai-Hong Wang; Can-Hui Jin; Guan-Yi Cui; Hong-Yu Li; Yin Wang; Juan-Juan Yu; Rui-Fang Wang; Xiao-Yu Tian
Journal:  Aging (Albany NY)       Date:  2020-02-21       Impact factor: 5.682

10.  Knowledge of Risk Factors, Symptoms and Barriers to Seeking Medical Help for Cervical Cancer among Omani Women Attending Sultan Qaboos University Hospital.

Authors:  Mohammed H Al-Azri; Maytha Al-Saidi; Eman Al-Mutairi; Sathiya M Panchatcharam
Journal:  Sultan Qaboos Univ Med J       Date:  2020-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.